Invivyd, Inc.

IVVD · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.4B · 122 employees
134
SEC Filings
$0.9231
Close 2026-09-23
122
Employees

Business Summary

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing monoclonal antibodies (mAbs) for the prevention and treatment of COVID-19. Its lead product, PEMGARDA (pemivibart), received FDA Emergency Use Authorization in March 2024 for pre-exposure prophylaxis of COVID-19 in certain immunocompromised patients. Its next-generation candidate, VYD2311, is being developed for broader COVID-19 prevention under a BLA pathway, leveraging the company's REVOLUTION clinical program.

Latest Stock Quote

IVVD 2026-09-23 $0.9231 O:$0.95 H:$0.965 L:$0.9113 Vol:6.9M VWAP:$0.928
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-092547EDGAR127K words
2025-03-202024-12-310000950170-25-042332EDGAR123K words
2024-03-282023-12-310000950170-24-037610EDGAR120K words
2023-03-232022-12-310000950170-23-009516EDGAR121K words
2022-03-312021-12-310000950170-22-005112EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001193125-26-349215EDGAR35K words
2025-11-062025-09-300001193125-25-268076EDGAR35K words
2025-08-142025-06-300000950170-25-109029EDGAR33K words
2025-05-152025-03-310000950170-25-071974EDGAR29K words
2024-11-142024-09-300000950170-24-126735EDGAR35K words
2024-08-142024-06-300000950170-24-096674EDGAR33K words
2024-05-092024-03-310000950170-24-057017EDGAR27K words
2023-11-092023-09-300000950170-23-062043EDGAR33K words
2023-08-102023-06-300000950170-23-041352EDGAR32K words
2023-05-112023-03-310000950170-23-021235EDGAR28K words
2022-11-102022-09-300000950170-22-024516EDGAR—
2022-08-152022-06-300000950170-22-017242EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-290001193125-26-406007EDGAR—
2026-09-010001193125-26-377493EDGAR2K words
2026-08-130001193125-26-349193EDGAR4K words
2026-07-240001193125-26-316066EDGAR1K words
2026-03-050001193125-26-092528EDGAR5K words
2026-01-080001193125-26-006997EDGAR3K words
2025-12-230001193125-25-329488EDGAR1K words
2025-11-240001193125-25-291992EDGAR1K words
2025-11-190001193125-25-288347EDGAR1K words
2025-11-060001193125-25-268057EDGAR5K words

134 total filings indexed. 107 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

covid-19-prevention-(pre-exposure-prophylaxis) covid-19-treatment immunocompromised-patient-care monoclonal-antibody-therapeutics cgcp-(current-good-clinical-practice) cglp-(current-good-laboratory-practice) cgmp-(current-good-manufacturing-practice) correlate-of-protection-(surrogate-of-clinical-efficacy) immunobridging-approach rt-pcr-confirmed-symptomatic-covid-19-endpoint

Company Identity

CIK0001832038
TickerIVVD
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.invivyd.com
Listed2021-08-06

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 1dc728de85d0608ab2d08e9b6345ab7b81ca4bdfafb63dcdc5ba029e74ac0793
parent: 8a64f61c78078f357946d9eb6f240fd1baf07bd7da13d051ecd04f2a9e194e5d
content hash: 10d34082f883d42ed0eaf7caa13a95c8430d1d33754f3e86631688c951201a6d
signed: 2026-09-29T19:01:47.949Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up IVVD using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on IVVD, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/IVVD (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.